| Dr Robert Thomas Baril, DO | |
|
Stephens Memorial Hospital, 181 Main St, Norway, ME 04268 | |
| (207) 393-3142 | |
| Not Available |
| Full Name | Dr Robert Thomas Baril |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 19 Years |
| Location | Stephens Memorial Hospital, Norway, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922190214 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | DO2738 (Maine) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 7426 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Houlton Regional Hospital | Houlton, ME | Hospital |
| Central Maine Medical Center | Lewiston, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Houlton Regional Hospital | 0042127946 | 24 |
| Western Maine Radiology, P.a. | 9931091352 | 3 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Western Maine Radiology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295722577 PECOS PAC ID: 9931091352 Enrollment ID: O20040329001080 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Calais Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922001049 PECOS PAC ID: 6901715176 Enrollment ID: O20040706000791 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Houlton Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386804268 PECOS PAC ID: 0042127946 Enrollment ID: O20041123000733 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Mount Desert Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790764512 PECOS PAC ID: 0941250963 Enrollment ID: O20050127000611 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Radiology Consultants Of Maine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164830139 PECOS PAC ID: 3779703897 Enrollment ID: O20141013000474 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Radadvantage A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376719666 PECOS PAC ID: 2163597899 Enrollment ID: O20180411001504 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Los Robles Radiologic Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730157215 PECOS PAC ID: 0446319206 Enrollment ID: O20180622000811 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Professional Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043348014 PECOS PAC ID: 0941298764 Enrollment ID: O20180820002145 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Silicon Valley Diagnostic Imaging Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629265806 PECOS PAC ID: 5496838518 Enrollment ID: O20181128000457 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Franklin Imaging Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497339709 PECOS PAC ID: 0244632677 Enrollment ID: O20210708000604 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Calais Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1922001049 PECOS PAC ID: 0345649158 Enrollment ID: O20210910001201 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Entity Name | Drs Russell Berkebile And Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750383519 PECOS PAC ID: 7315930229 Enrollment ID: O20211124001123 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Thomas Baril, DO 5955 Zeamer Ave, Anchorage, AK 99506-3702 Ph: (580) 907-6767 | Dr Robert Thomas Baril, DO Stephens Memorial Hospital, 181 Main St, Norway, ME 04268 Ph: (207) 393-3142 |
News Archive
Patients who experience the deadliest form of heart attack-ST segment elevation myocardial infarction (STEMI)-and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
The neurocognitive function of patients with major depression who fall into the "soft" bipolar spectrum resembles that of patients with bipolar II disorder rather than those with unipolar depression, say researchers.
› Verified 4 days ago
Edwin J Kracji, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 181 Main St, Norway, ME 04268 Phone: 207-743-5933 | |
Reynold Villedrouin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 181 Main St, Norway, ME 04268 Phone: 207-743-5933 | |
William Jay Portner, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 181 Main St, Norway, ME 04268 Phone: 207-743-5933 |